Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Healthcare doesn't get the hype that other industries -- say, technology -- get. However, there arguably isn't an industry more important to humankind's well-being. That's especially true in the United States, the world's most lucrative healthcare market -- a multi-trillion-dollar behemoth where investment opportunities abound.
Sifting through the industry revealed three blue chip stocks with stellar records of execution, future growth opportunities, and an enticing dividend. They offer both passive income and reinvestment potential that could boost overall returns.
Here is why Johnson Johnson (NYSE: JNJ), Abbott Labs (NYSE: ABT), and (NYSE: PFE) should all be on your radar as a long-term investor. You can own a share of each for less than $1,000 all-in.
Source Fool.com
Pfizer Inc. Aktie
Die Pfizer Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 40 € für Pfizer Inc. weist auf eine Steigerung von über 50% gegenüber dem aktuellen Kurs von 26.38 € hin.
